Faisal Al-Akayleh | pharmaceutical green chemistry | Excellence in Innovation

Prof Faisal Al-Akayleh, university of Petra, Jordan

Professor Faisal T. Al-Akayleh, PhD, is a distinguished pharmaceutical researcher, inventor, and consultant. With extensive experience in nanotechnology, drug delivery, and pharmaceutical material science, he has published five patents and contributed to groundbreaking research. He is a member of the Jordan FDA, Head of the Department of Pharmaceutics at the University of Petra, and serves on several prestigious boards. Al-Akayleh has received the El Hassan Bin Talal Award for Scientific Excellence in 2018. His research spans across various fields, including drug delivery, environmental pollution, and therapeutic innovations. 💊🔬🎓💡📑

Publication Profile

Google Scholar

Education

Prof. Faisal Al-Akayleh holds a Ph.D. from Baghdad University (2003), an MS from the same institution (1998), and a BS from the University of Jordan, Amman (1994). With extensive academic credentials, Prof. Al-Akayleh has dedicated his career to higher education and research. His expertise spans various fields, with a strong foundation built on his advanced studies. Throughout his academic journey, he has contributed significantly to his field, shaping the minds of future professionals. 🎓📚🔬

Professional Experience

Prof. Faisal Al-Akayleh is a dedicated pharmacist and the owner of multiple successful pharmacies in Amman. Since 1999, he has owned Al Wasan Pharmacy, providing quality healthcare services to the community. In 2021, he expanded his reach by opening Ghasan Pharmacy and Faten Pharmacy, further cementing his role as a trusted healthcare provider. His extensive experience and commitment to patient care make him a well-respected figure in the field of pharmacy. 💊🏥💼📈

Pharmaceutical Researcher

Prof. Faisal Al-Akayleh is a distinguished pharmacist with extensive contributions to pharmaceutical research. He has developed novel delivery systems and excipients, including a superdisintegrant for solid dosage forms, sustained release matrix systems for oral drug delivery, and a biodegradable, natural surface-active agent. His work also involves creating innovative systems for the oral delivery of proteins like insulin and developing a cream-base for active ingredients and plant extracts. Additionally, Prof. Al-Akayleh has worked on an obesity treatment system and prepared complete product master files for sustained release solid dosage forms. He has also monitored clinical trials of JPM oral insulin using the Euglycemic Clamp technique. 💊🔬💡🩺

Research Experience

Prof. Faisal Al-Akayleh worked as the Research and Development Manager at Trium Pharma in Jordan (2004-2005), where he addressed technical challenges in developing novel drug delivery systems. He assessed initial requirements for these systems and implemented effective solutions while training his team on analytical methodologies and formulation aspects. Later, he joined United Pharmaceutical Company (2005-2006) as a Scientist Researcher, focusing on developing transdermal patches for Fentanyl. Throughout his career, he contributed significantly to advancing pharmaceutical technologies and ensuring effective drug delivery solutions. 🧴💊👨‍🔬💡

Award

Prof. Faisal Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence in 2018, recognizing his outstanding contributions to scientific research. The award was presented for his involvement in a groundbreaking project, “Development of Oral Insulin Delivery System,” in collaboration with university colleagues and the Jordan Pharmaceutical Manufacturing Company (JPM). This innovative project aimed to revolutionize the delivery of insulin, improving the lives of individuals with diabetes. The recognition underscores Prof. Al-Akayleh’s dedication to advancing medical science and fostering collaborative research. 🏆💉🔬🤝

Research Focus

Faisal Al-Akayleh’s research focuses on the development and application of novel pharmaceutical systems, particularly in the areas of deep eutectic solvents (DES), transdermal delivery systems, and the use of biopolymers like chitosan in drug delivery and functional foods. His work involves exploring the antimicrobial properties, therapeutic applications, and enhanced bioavailability of various pharmaceutical compounds, including risperidone and curcumin. Additionally, Al-Akayleh’s research includes investigating the potential of chitosan as a functional food and meal replacement. His studies contribute significantly to the fields of pharmaceutical science, drug formulation, and health applications. 📚💊🌿🧴

Publication Top Notes

A review of the antiviral activity of Chitosan, including patented applications and its potential use against COVID‐19

Therapeutic deep eutectic system of capric acid and menthol: Characterization and pharmaceutical application

A novel eutectic-based transdermal delivery system for risperidone

Antimicrobial potential of natural deep eutectic solvents

New insight into single phase formation of capric acid/menthol eutectic mixtures by Fourier-transform infrared spectroscopy and differential scanning calorimetry

Deep eutectic liquid as transdermal delivery vehicle of Risperidone

Evaluation of a functional food preparation based on chitosan as a meal replacement diet